155 related articles for article (PubMed ID: 19652895)
1. Polymorphisms in VKORC1 and GGCX are not major genetic determinants of vitamin K-dependent coagulation factor activity in Western Germans.
Watzka M; Westhofen P; Hass M; Marinova M; Pötzsch B; Oldenburg J
Thromb Haemost; 2009 Aug; 102(2):418-20. PubMed ID: 19652895
[No Abstract] [Full Text] [Related]
2. Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis.
de Visser MC; Roshani S; Rutten JW; van Hylckama Vlieg A; Vos HL; Rosendaal FR; Reitsma PH
Thromb Haemost; 2011 Sep; 106(3):563-5. PubMed ID: 21800014
[No Abstract] [Full Text] [Related]
3. Vitamin K-dependent coagulation factors deficiency.
Brenner B; Kuperman AA; Watzka M; Oldenburg J
Semin Thromb Hemost; 2009 Jun; 35(4):439-46. PubMed ID: 19598072
[TBL] [Abstract][Full Text] [Related]
4. Common VKORC1 and GGCX polymorphisms associated with warfarin dose.
Wadelius M; Chen LY; Downes K; Ghori J; Hunt S; Eriksson N; Wallerman O; Melhus H; Wadelius C; Bentley D; Deloukas P
Pharmacogenomics J; 2005; 5(4):262-70. PubMed ID: 15883587
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population.
Kimura R; Kokubo Y; Miyashita K; Otsubo R; Nagatsuka K; Otsuki T; Sakata T; Nagura J; Okayama A; Minematsu K; Naritomi H; Honda S; Sato K; Tomoike H; Miyata T
Int J Hematol; 2006 Dec; 84(5):387-97. PubMed ID: 17189218
[TBL] [Abstract][Full Text] [Related]
6. Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke.
Shyu HY; Fong CS; Fu YP; Shieh JC; Yin JH; Chang CY; Wang HW; Cheng CW
Clin Chim Acta; 2010 Jun; 411(11-12):840-5. PubMed ID: 20193673
[TBL] [Abstract][Full Text] [Related]
7. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.
Kimura R; Miyashita K; Kokubo Y; Akaiwa Y; Otsubo R; Nagatsuka K; Otsuki T; Okayama A; Minematsu K; Naritomi H; Honda S; Tomoike H; Miyata T
Thromb Res; 2007; 120(2):181-6. PubMed ID: 17049586
[TBL] [Abstract][Full Text] [Related]
8. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
[TBL] [Abstract][Full Text] [Related]
9. VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding.
Spohn G; Kleinridders A; Wunderlich FT; Watzka M; Zaucke F; Blumbach K; Geisen C; Seifried E; Müller C; Paulsson M; Brüning JC; Oldenburg J
Thromb Haemost; 2009 Jun; 101(6):1044-50. PubMed ID: 19492146
[TBL] [Abstract][Full Text] [Related]
10. Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin.
Vecsler M; Loebstein R; Almog S; Kurnik D; Goldman B; Halkin H; Gak E
Thromb Haemost; 2006 Feb; 95(2):205-11. PubMed ID: 16493479
[TBL] [Abstract][Full Text] [Related]
11. Novel splice site mutations in the gamma glutamyl carboxylase gene in a child with congenital combined deficiency of the vitamin K-dependent coagulation factors (VKCFD).
Titapiwatanakun R; Rodriguez V; Middha S; Dukek BA; Pruthi RK
Pediatr Blood Cancer; 2009 Jul; 53(1):92-5. PubMed ID: 19340858
[TBL] [Abstract][Full Text] [Related]
12. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
Loriot MA; Beaune P
Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
[TBL] [Abstract][Full Text] [Related]
13. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex.
Oldenburg J; von Brederlow B; Fregin A; Rost S; Wolz W; Eberl W; Eber S; Lenz E; Schwaab R; Brackmann HH; Effenberger W; Harbrecht U; Schurgers LJ; Vermeer C; Müller CR
Thromb Haemost; 2000 Dec; 84(6):937-41. PubMed ID: 11154138
[TBL] [Abstract][Full Text] [Related]
14. Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status.
Crosier MD; Peter I; Booth SL; Bennett G; Dawson-Hughes B; Ordovas JM
J Nutr Sci Vitaminol (Tokyo); 2009 Apr; 55(2):112-9. PubMed ID: 19436136
[TBL] [Abstract][Full Text] [Related]
15. The vitamin K cycle.
Oldenburg J; Marinova M; Müller-Reible C; Watzka M
Vitam Horm; 2008; 78():35-62. PubMed ID: 18374189
[TBL] [Abstract][Full Text] [Related]
16. Founder mutation Arg485Pro led to recurrent compound heterozygous GGCX genotypes in two German patients with VKCFD type 1.
Rost S; Geisen C; Fregin A; Seifried E; Müller CR; Oldenburg J
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):503-7. PubMed ID: 16905958
[TBL] [Abstract][Full Text] [Related]
17. Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency.
Darghouth D; Hallgren KW; Shtofman RL; Mrad A; Gharbi Y; Maherzi A; Kastally R; LeRicousse S; Berkner KL; Rosa JP
Blood; 2006 Sep; 108(6):1925-31. PubMed ID: 16720838
[TBL] [Abstract][Full Text] [Related]
18. VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.
Lacombe J; Rishavy MA; Berkner KL; Ferron M
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321368
[TBL] [Abstract][Full Text] [Related]
19. Warfarin and the vitamin K-dependent gamma-carboxylation system.
Wallin R; Hutson SM
Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K-dependent gamma-glutamylcarboxylation: an ancient posttranslational modification.
Bandyopadhyay PK
Vitam Horm; 2008; 78():157-84. PubMed ID: 18374194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
